Shareholders who hold their shares in brokerage accounts or in "street name" will have their positions automatically adjusted to reflect the reverse stock split, subject to each broker's particular ...

Mines Biomed, a molecular genetics diagnostic company, has entered into a collaborative agreement with Thermo Fisher ...

Mainz Biomed (MYNZ) announced a 1-for-40 reverse stock split of its issued and outstanding shares. The reverse stock split was authorized by ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

H.C. Wainwright downgraded Mainz Biomed (MYNZ) to Neutral from Buy without a price target after the company presented key data from the eAArly DETECT study, showing 97% sensitivity for colorectal ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early ...

From clinical developments to an upcoming FDA trial anticipated in 2025, Mainz Biomed NV MYNZ, the molecular genetics diagnostic company, is making headway in growing its business on its path to ...

Mainz Biomed NV (NASDAQ: MYNZ) announced a major new collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO) to jointly develop a next-generation colorectal cancer screening product.

Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort (e): Sonstiges Mainz Biomed gibt Aktienzusammenlegung bekannt 29.11 ...

BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostics company, has announced a distribution partnership with Praxisdienst, a... Mainz Biomed N.V ...

Mainz Biomed, ein Unternehmen aus dem Markt "Pharmaceuticals Biotechnologie & Life Sciences", notiert aktuell (Stand Uhr) mit 1.078 EUR unverändert. Unser Analystenteam hat Mainz Biomed auf Basis ...

Investing.com - Mainz Biomed BV reported on Wednesday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations. Mainz Biomed BV... Mainz Biomed ...